Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease?
ABSTRACT The prevalence of nephrolithiasis is increasing worldwide. Despite advances in understanding the pathogenesis of lithiasis, few studies have demonstrated that specific clinical interventions reduce the recurrence of nephrolithiasis. The aim of this review is to analyze the current data and...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Sociedade Brasileira de Nefrologia
2024-02-01
|
| Серія: | Brazilian Journal of Nephrology |
| Предмети: | |
| Онлайн доступ: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002024005005603&tlng=pt |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|